According to the latest analysis, the global colostrum market value is expected to be valued at US$ 3,179.5 million in 2024 and is set to reach US$ 6,923.5 million by 2034. Over the next decade, global colostrum demand will likely increase at a healthy CAGR of 8.1%.
Colostrum chewable tablets are expected to remain highly sought-after colostrum supplements. This is due to their multiple advantages, including convenience and palatability. The target segment will likely total a market valuation of US$ 1,126.3 million in 2034.
Several factors are expected to propel demand for colostrum products during the assessment period. These include:
- Increasing awareness among consumers about the potential health benefits of colostrum, including its high nutritional value and immune-boosting properties
- Growing interest in natural products
- Expanding the application of colostrum in nutraceuticals, infant formulas, and dietary supplements
- Escalating demand for functional foods
Colostrum is rich in immunoglobulins and has other immune-boosting properties. This is expected to drive its demand throughout the assessment period.
With consumers becoming more health-conscious and seeking ways to enhance their immune systems, there is a growing demand for colostrum-based products. This is a key factor expected to boost the growth of the colostrum industry.
Colostrum is widely used as an ingredient in several dietary supplements, nutraceuticals, and functional foods. Thus, increasing demand and consumption of these products will likely bolster sales of colostrum during the assessment period.
Colostrum is also gaining immense traction in the infant formula industry. It is becoming a valuable ingredient in infant formula owing to its nutritional benefits. This is another driver for the global colostrum industry.
Top manufacturers are diversifying their product offerings by developing a range of colostrum-based products, such as powders, supplements, capsules, and skincare products. This allows them to cater to different consumer preferences and needs.
The booming e-commerce is making it easy for colostrum manufacturers to expand their customer base. With online marketplaces, manufacturers are expanding their reach into new markets and tapping into the global market. This will create lucrative growth opportunities for colostrum manufacturers.
Key Takeaways from the Colostrum Report:
- The global market for colostrum is expected to reach a valuation of US$ 6,923.5 million by 2034.
- Global demand for colostrum will likely rise at 1% CAGRthrough 2034.
- Based on product type, the chewable tablets segment is projected to account for a revenue share of 7% in 2024.
- By end-use, the online retailing segment is set to grow at a CAGR of 5% through 2034.
- North America is set to account for a prominent global market share of 6% by 2034.
- Japan’s market is poised to exhibit a value CAGR of 6% from 2024 to 2034.
“The colostrum market continues to thrive, driven by rising consumer interest in natural immune support and sports nutrition. Manufacturers are innovating with diverse product offerings, addressing sustainability concerns, and leveraging online platforms for direct sales. Scientific research and collaborations contribute to the market’s credibility, aligning with clean labels and personalized nutrition trends,” – Nandini Roy Choudhury, Client Partner at Future Market Insights
Who is Winning?
Colostrum BioTec GmbH, Biostrum Nutritech Pvt. Ltd., Zuche Pharmaceuticals, Agati Healthcare Pvt. Good Health New Zealand, Biodane Pharma A/S, Ingredia Nutritional (Ingredia S.A.), Ltd., McePharma, Cure Nutraceuticals Pvt. Ltd., Australian by Nature, La Belle Inc., NIG Nutritionals Limited, Biotaris B.V., Sterling Technology, and Pantheryx Inc. are key colostrum manufacturers listed in the report.
Top players are constantly upgrading their portfolios by launching new colostrum products. They also use strategies like advertisements, collaborations, partnerships, mergers, acquisitions, agreements, and facility expansions to stay ahead of the competition.
For instance,
- In 2021, Cogent Breeding unveiled a new Primestart colostrum product, which is a replacer for the new-born calf.
- In 2022, PanTheryx introduced a supplement formulated for the healthcare practitioner channel, which provides extra immune support and digestive health supplements.
Drive Your Growth Strategy Purchase the Report for Key Insights: https://www.futuremarketinsights.com/checkout/897
Get More Valuable Insights
Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global colostrum market, presenting historical demand data (2019 to 2023) and forecast statistics for the period from 2024 to 2034.
The study offers compelling insights into the colostrum industry based on nature (organic and conventional), product type (whole and colostrum finished products), end-use (B2B and B2C), and animal type (cow and buffalo) across several regions
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact US:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube